Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues:      
Total revenues $ 196,245 $ 241,544 $ 163,562
Operating costs and expenses:      
Cost of Captisol 52,827 62,176 30,419
Amortization of intangibles 34,237 34,222 11,642
Research and development 36,082 32,105 40,503
General and administrative 70,062 46,790 60,012
Other operating (income) expense 0 (37,600) 600
Total operating costs and expenses 193,208 137,693 143,176
Income from continuing operations 3,037 103,851 37,500
Other income (expense):      
Gain (loss) from short-term investments 28,540 (5,263) (16,933)
Interest income 2,046 886 8,078
Interest expense (1,799) (19,619) (27,415)
Other income (expense), net 4,187 (7,650) 62
Total other expense, net 32,974 (31,646) (36,208)
Income before income tax from continuing operations 36,011 72,205 1,292
Income tax benefit (expense) (41,230) 4,148 5,306
Net income (loss) from continuing operations (5,219) 76,353 6,598
Net loss from discontinued operations (28,142) (19,215) (9,583)
Net income (loss): $ (33,361) $ 57,138 $ (2,985)
Earnings Per Share [Abstract]      
Basic net income (loss) from continuing operations (USD per share) $ (0.31) $ 4.59 $ 0.41
Basic net income (loss) from discontinued operations (USD per share) (1.67) (1.16) (0.59)
Basic net income (loss) per share (USD per share) $ (1.98) $ 3.44 $ (0.18)
Shares used in basic per share calculation (shares) 16,868,000 16,630,000 16,185,000
Diluted net income (loss) from continuing operations (USD per share) $ (0.31) $ 4.43 $ 0.39
Diluted net income (loss) from discontinued operations (USD per share) (1.67) (1.11) (0.57)
Diluted net income (loss) per share (USD per share) $ (1.98) $ 3.31 $ (0.18)
Shares used in diluted per share calculation (shares) 16,868,000 17,246,000 16,825,000
Royalties      
Revenues:      
Total revenues $ 72,527 $ 48,927 $ 33,796
Captisol      
Revenues:      
Total revenues 104,495 164,250 109,959
Contract revenue      
Revenues:      
Total revenues 19,223 28,367 19,807
Vernalis      
Operating costs and expenses:      
Gain from sale of Vernalis R&D $ 0 $ 0 $ 17,114